Disc Medicine Inc. (IRON)
NASDAQ: IRON
· Real-Time Price · USD
46.86
1.74 (3.86%)
At close: May 29, 2025, 3:59 PM
46.87
0.02%
After-hours: May 29, 2025, 04:34 PM EDT
Company Description
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.
It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis.
The company is based in Watertown, Massachusetts.
Disc Medicine Inc.
| Country | United States |
| IPO Date | Aug 12, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 94 |
| CEO | Dr. John D. Quisel Esq., J.D., Ph.D. |
Contact Details
Address: 321 Arsenal Street Watertown, Massachusetts United States | |
| Website | https://www.discmedicine.com |
Stock Details
| Ticker Symbol | IRON |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001901203 |
| CUSIP Number | |
| ISIN Number | US2546041011 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. John D. Quisel Esq., J.D., Ph.D. | Chief Executive Officer, President & Director |
| Dr. Rahul Khara J.D., Pharm.D. | Chief Legal Officer & Secretary |
| Jean M. Franchi CPA | Chief Financial Officer |
| Dr. Brian MacDonald ChB, MB, Ph.D. | Founder & Chair of Scientific Advisory Board |
| Dr. Donald William Nicholson Ph.D. | Executive Chairman |
| Dr. Rahul Rajan Kaushik Ph.D. | Chief Technical Officer |
| Dr. William Jacob Savage M.D., Ph.D. | Chief Medical Officer |
| Jonathan Yu M.B.A. | Chief Opearating Officer |
| Pamela Stephenson M.P.H. | Chief Commercial Officer |
| Srikanth Venkatraman Ph.D. | Senior Vice President & Head of Chemistry |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 16, 2025 | PRE 14A | Filing |
| May 15, 2025 | DEFM14A | Filing |
| May 15, 2025 | 424B3 | Filing |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 12, 2025 | SCHEDULE 13G | Filing |
| May 06, 2025 | S-4/A | [Amend] Filing |
| Apr 30, 2025 | S-4/A | [Amend] Filing |
| Apr 14, 2025 | S-4/A | [Amend] Filing |
| Apr 07, 2025 | S-4/A | [Amend] Filing |